Business Context and Reporting Period
This Form 8-K is a current report filed by Capricor Therapeutics, Inc. on March 26, 2014. The filing serves as a Regulation FD disclosure regarding an upcoming investor presentation by the Company's Chief Executive Officer, Dr. Linda Marbán.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is an event notification and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely announces a scheduled corporate event.
Guidance, Outlook, and Management Commentary
- Event: Dr. Linda Marbán, CEO, is scheduled to present at the 2nd Annual ARM Regen Med Investor Day.
- Date and Time: March 26, 2014, at approximately 1:45 p.m. Eastern time.
- Location: The Metropolitan Club in New York City.
- Materials: Presentation slides are available on the "Investors" section of the Company's website (www.capricor.com) and will be archived for at least 30 days.
- Legal Status: The information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the availability and content of the presentation slides on the Company's investor website.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance data, as this 8-K contains none.
- Monitor subsequent press releases or filings for any updates resulting from the investor day presentation.